Associate Sponsors

Co-sponsor

IP waiver for Covid-19 vaccine on Piyush Goyal-WTO chief meet agenda

The latest push by India and South Africa on Trade-Related Intellectual Property Rights (TRIPS) waiver on Covid-19 vaccine is one of the agenda

Piyush Goyal
Piyush Goyal (Photo: PTI)
Shreya Nandi New Delhi
2 min read Last Updated : Oct 18 2021 | 6:10 AM IST
Union Commerce and Industry Minister Piyush Goyal is expected to meet World Trade Organization (WTO) Director General Ngozi Okonjo-Iweala in New Delhi this week to discuss key issues related to global trade.
 
Okonjo-Iweala's maiden visit to India since her appointment in February comes in the backdrop of the crucial WTO 12th ministerial conference (MC12) that will be held on 30 November-3 December in Geneva.
 
This ministerial conference is the highest decision-making body of the WTO and can even take decisions on all matters under any of the multilateral trade agreements. The MC customarily meets every two years, but this time it is being held after a gap of four years as it was postponed due to the outbreak of the pandemic.
 
“The meeting between Goyal and Okonjo-Iweala is expected to take place on October 22. A meeting may also take place between Prime Minister Narendra Modi and the WTO DG,” a senior government official said.
 
Long-pending issues related to agriculture and fisheries are likely to be discussed in the meeting. The latest push by India and South Africa on Trade-Related Intellectual Property Rights (TRIPS) waiver on Covid-19 vaccine is also the agenda. Moreover, various reforms at the WTO can also be discussed. “As such, with respect to any reforms, India will pitch for reforms (if and when needed) should be inclusive. Apart from that the WTO, as such, should be a consensus-based body and every policy implemented by any country must be transparent,” another government official said.
 
“India is not the only country that the (WTO) DG is meeting ahead of WTO’s MC12. She is meeting representatives from other countries as well in person, to understand every nation’s point of view on key trade related issues,” he added.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Piyush GoyalWTOCoronavirus Vaccineintellectual property rights

Next Story